- Home
- POOL vs VTAK Comparison
POOL vs VTAK Comparison
Compare POOL & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- VTAK
- Stock Information
- Founded
- POOL 1993
- VTAK 2002
- Country
- POOL United States
- VTAK United States
- Employees
- POOL N/A
- VTAK N/A
- Industry
- POOL Industrial Specialties
- VTAK Medical/Dental Instruments
- Sector
- POOL Consumer Discretionary
- VTAK Health Care
- Exchange
- POOL Nasdaq
- VTAK Nasdaq
- Market Cap
- POOL N/A
- VTAK 1.1M
- IPO Year
- POOL 1995
- VTAK 2018
- Fundamental
- Price
- POOL $368.31
- VTAK $0.35
- Analyst Decision
- POOL Hold
- VTAK
- Analyst Count
- POOL 9
- VTAK 0
- Target Price
- POOL $352.75
- VTAK N/A
- AVG Volume (30 Days)
- POOL 245.9K
- VTAK 248.5K
- Earning Date
- POOL 10-24-2024
- VTAK 08-14-2024
- Dividend Yield
- POOL 1.31%
- VTAK N/A
- EPS Growth
- POOL N/A
- VTAK N/A
- EPS
- POOL 11.87
- VTAK N/A
- Revenue
- POOL $5,368,051,000.00
- VTAK $436,000.00
- Revenue This Year
- POOL N/A
- VTAK $637.10
- Revenue Next Year
- POOL $4.11
- VTAK $177.13
- P/E Ratio
- POOL $31.04
- VTAK N/A
- Revenue Growth
- POOL N/A
- VTAK 140.88
- 52 Week Low
- POOL $293.51
- VTAK $0.31
- 52 Week High
- POOL $422.73
- VTAK $8.40
- Technical
- Relative Strength Index (RSI)
- POOL 55.37
- VTAK 28.30
- Support Level
- POOL $359.74
- VTAK $0.35
- Resistance Level
- POOL $368.83
- VTAK $0.38
- Average True Range (ATR)
- POOL 7.02
- VTAK 0.04
- MACD
- POOL -1.23
- VTAK 0.04
- Stochastic Oscillator
- POOL 41.32
- VTAK 18.75
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.